Giving Medication to Children The director of
FDA's Office of Pediatric Therapeutics discusses what parents should know about medication use in children.
Source: www.fda.govRecalls and Safety Alerts: Raptiva Withdrawn from the Market Genentech is conducting a phased market withdrawal of the psoriasis drug Raptiva (efalizumab). The company is doing this because taking the drug carries the risk of developing progressive multifocal leukoencephalopathy (PML). PML, which is caused by...
Source: www.accessdata.fda.govWarning on Hydroxycut Products FDA is warning consumers to stop using Hydroxycut products because of serious health risks. One death due to liver failure has been reported to the agency.
Source: www.fda.govFDA Promotes Openness and Transparency to Public FDA is working to make useful information about
FDA activities and decision making more readily available to the public.
Source: www.fda.gov
# posted by Network @ 5:10 PM